Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Equity (Details 1)

v3.8.0.1
Equity (Details 1) - $ / shares
 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Disclosure of terms and conditions of share-based payment arrangement [line items]      
No. of options, Outstanding at the beginning of the year 32,888,472 45,532,659 17,963,346
No. of options, Granted 9,586,000 [1] 28,100,000
No. of options, Expired (1,065,305) (4,076,167) (318,894)
No. of options, Forfeited (764,375) (4,947,135) (119,748)
No. of options, Exercised (3,620,885) (92,045)
No. of options, Outstanding at the end of the year 40,644,792 32,888,472 45,532,659
No. of options, Exercisable at the end of the year 20,922,506 14,350,118 11,700,665
Weighted average of exercise price, Outstanding at the beginning of the year $ 0.65 $ 0.59 $ 0.56
Weighted average of exercise price, Granted 0.56 0.61
Weighted average of exercise price, Expired 0.58 0.6 0.44
Weighted average of exercise price, Forfeited 0.6 0.35 0.84
Weighted average of exercise price, Exercised 0.26 0.3
Weighted average of exercise price, Outstanding at the end of the year 0.63 0.65 0.59
Weighted average of exercise price, Exercisable at the end of the year 0.57 $ 0.56 $ 0.49
Bottom of range [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Weighted average of exercise price, Granted 0.56    
Top of range [member]      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Weighted average of exercise price, Granted $ 1.39    
[1] Not including options to Directors and CEO which are subject to shareholder approval.